Skip to main content

Advertisement

Fig. 3 | Cancer Cell International

Fig. 3

From: miR-93-5p enhance lacrimal gland adenoid cystic carcinoma cell tumorigenesis by targeting BRMS1L

Fig. 3

BRMS1L targeted by miR-93-5p. a Schematic graph of the 3′UTR of BRMS1L predicted binding sites with miR-93-5p and their mutant. b Quantitative analysis of the luciferase activity in 293T cells of reporter vectors containing the BRMS1L 3′UTR of wild type or mutant and miR-93-5p transfection. *P < 0.05 compared with miRNA mimics cells. c BRMS1L expression in L3–2 and L3–5 cells by western blot under miRNA mimics or miR-93-5p transfection

Back to article page